Magnetar Financial LLC Agios Pharmaceuticals, Inc. Transaction History

Magnetar Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$41.92 - $58.18 $320,771 - $445,193	-7,652 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$52.06 - $61.27 $398,363 - $468,838	7,652 New	7,652 $422,000
Q1 2021 May 14, 2021	SELL	$44.23 - $57.5 $226,590 - $294,572	-5,123 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$33.21 - $46.54 $250,702 - $351,330	-7,549 Reduced 59.57%	5,123 $222,000
Q3 2020 Nov 16, 2020	BUY	$33.87 - $55.93 $429,200 - $708,744	12,672 New	12,672 $444,000
Q2 2020 Aug 14, 2020	SELL	$34.45 - $53.48 $273,085 - $423,935	-7,927 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$31.52 - $53.81 $249,859 - $426,551	7,927 New	7,927 $281,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.05B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Magnetar Financial LLC with notifications on news.